{"id":821,"date":"2026-04-16T06:08:33","date_gmt":"2026-04-16T06:08:33","guid":{"rendered":"https:\/\/satoriocs.com\/blogs\/?p=821"},"modified":"2026-04-16T06:08:34","modified_gmt":"2026-04-16T06:08:34","slug":"iso-standards-directory-complete-reference-list-for-medical-devices-ivds-cosmetics-healthcare","status":"publish","type":"post","link":"https:\/\/satoriocs.com\/blogs\/iso-standards-directory-complete-reference-list-for-medical-devices-ivds-cosmetics-healthcare\/","title":{"rendered":"ISO Standards Directory \u2013 Complete Reference List for Medical Devices, IVDs, Cosmetics & Healthcare"},"content":{"rendered":"\n

The International Organization for Standardization (ISO) has released multiple updated standards for medical devices, IVDs, and healthcare systems in 2025 and 2026.<\/p>\n\n\n\n

This article provides a comprehensive list<\/strong> of key ISO standards relevant to medical device manufacturers, quality professionals, and regulatory affairs teams.<\/p>\n\n\n\n

Top Medical Device Standards (Recently Published or Reviewed)<\/strong><\/strong><\/td><\/tr>
Sno.<\/strong><\/td>Standard<\/strong><\/td>Title<\/strong><\/td>Published\/Reviewed<\/strong><\/td><\/tr>
1<\/td>ISO 14155<\/td>Clinical investigation of medical devices for human subjects \u2014 Good clinical practice<\/td>2026<\/td><\/tr>
2<\/td>ISO 20417<\/td>Medical devices \u2014 Information to be supplied by the manufacturer<\/td>2026<\/td><\/tr>
3<\/td>ISO 10993-1<\/td>Biological evaluation of medical devices \u2014 Part 1: Requirements and general principles<\/td>2025<\/td><\/tr>
4<\/td>ISO 80601-2-61<\/td>Medical electrical equipment \u2014 Part 2-61: Pulse oximeter equipment<\/td>2026<\/td><\/tr>
5<\/td>ISO 80601-2-74<\/td>Medical electrical equipment \u2014 Part 2-74: Respiratory humidifying equipment<\/td>2026<\/td><\/tr>
6<\/td>ISO 15223-1<\/td>Medical devices \u2014 Symbols to be used with information supplied by the manufacturer<\/td>2021 (Reviewed)<\/td><\/tr>
7<\/td>ISO 13485<\/td>Medical devices \u2014 Quality management systems \u2014 Requirements for regulatory purposes<\/td>2025<\/td><\/tr>
8<\/td>ISO 14971<\/td>Medical devices \u2014 Application of risk management<\/td>2025<\/td><\/tr>
9<\/td>ISO 22367<\/td>Medical laboratories \u2014 Application of risk management to medical laboratories<\/td>2026<\/td><\/tr>
10<\/td>ISO 80601-2-69<\/td>Medical electrical equipment \u2014 Part 2-69: Oxygen concentrator equipment<\/td>2026<\/td><\/tr>
11<\/td>IEC 62366-1<\/td>Medical devices \u2014 Part 1: Application of usability engineering<\/td>2021<\/td><\/tr>
12<\/td>IEC 62304<\/td>Medical device software \u2014 Software life cycle processes<\/td>2021<\/td><\/tr>
13<\/td>ISO 15189<\/td>Medical laboratories \u2014 Requirements for quality and competence<\/td>2022<\/td><\/tr>
14<\/td>ISO 7101<\/td>Healthcare organization management \u2014 Management systems for quality in healthcare organizations<\/td>2023<\/td><\/tr>
Biological Evaluation & Biocompatibility Standards<\/strong><\/td><\/tr>
15<\/td>ISO 10993-12<\/td>Biological evaluation of medical devices \u2014 Part 12: Sample preparation and reference materials<\/td>2021<\/td><\/tr>
16<\/td>ISO 10993-17<\/td>Biological evaluation of medical devices \u2014 Part 17: Toxicological risk assessment<\/td>2023<\/td><\/tr>
17<\/td>ISO 10993-18<\/td>Biological evaluation of medical devices \u2014 Part 18: Chemical characterization<\/td>2025<\/td><\/tr>
18<\/td>ISO 10993-23<\/td>Biological evaluation of medical devices \u2014 Part 23: Tests for irritation<\/td>2021<\/td><\/tr>
19<\/td>ISO 10993-4<\/td>Biological evaluation of medical devices \u2014 Part 4: Tests for interactions with blood<\/td>2017<\/td><\/tr>
20<\/td>ISO 10993-10<\/td>Biological evaluation of medical devices \u2014 Part 10: Tests for skin sensitization<\/td>2021<\/td><\/tr>
21<\/td>ISO 10993-5<\/td>Biological evaluation of medical devices \u2014 Part 5: Tests for in vitro cytotoxicity<\/td>2022<\/td><\/tr>
22<\/td>ISO 10993-11<\/td>Biological evaluation of medical devices \u2014 Part 11: Tests for systemic toxicity<\/td>2017<\/td><\/tr>
23<\/td>ISO 10993-7<\/td>Biological evaluation of medical devices \u2014 Part 7: Ethylene oxide sterilization residuals<\/td>2008<\/td><\/tr>
24<\/td>ISO 10993-3<\/td>Biological evaluation of medical devices \u2014 Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity<\/td>2014<\/td><\/tr>
25<\/td>ISO 10993-6<\/td>Biological evaluation of medical devices \u2014 Part 6: Tests for local effects after implantation<\/td>2016<\/td><\/tr>
26<\/td>ISO\/TR 24971<\/td>Medical devices \u2014 Guidance on the application of ISO 14971<\/td>2020<\/td><\/tr>
Sterilization Standards<\/strong><\/td><\/tr>
27<\/td>ISO 11135<\/td>Sterilization of health-care products \u2014 Ethylene oxide<\/td>2014<\/td><\/tr>
28<\/td>ISO 11137-1<\/td>Sterilization of health care products \u2014 Radiation \u2014 Part 1: Requirements<\/td>2025<\/td><\/tr>
29<\/td>ISO 17665<\/td>Sterilization of health care products \u2014 Moist heat<\/td>2024<\/td><\/tr>
30<\/td>ISO 11607-1<\/td>Packaging for terminally sterilized medical devices \u2014 Part 1: Requirements<\/td>2024<\/td><\/tr>
31<\/td>ISO 11607-2<\/td>Packaging for terminally sterilized medical devices \u2014 Part 2: Validation requirements<\/td>2024<\/td><\/tr>
32<\/td>ISO 11737-1<\/td>Sterilization of health care products \u2014 Microbiological methods \u2014 Part 1: Population of microorganisms<\/td>2018<\/td><\/tr>
33<\/td>ISO 11737-2<\/td>Sterilization of health care products \u2014 Microbiological methods \u2014 Part 2: Tests of sterility<\/td>2025<\/td><\/tr>
34<\/td>ISO 11737-3<\/td>Sterilization of health care products \u2014 Microbiological methods \u2014 Part 3: Bacterial endotoxin testing<\/td>2023<\/td><\/tr>
35<\/td>ISO 14937<\/td>Sterilization of health care products \u2014 General requirements for characterization of a sterilizing agent<\/td>2009<\/td><\/tr>
36<\/td>ISO 22441<\/td>Sterilization of health care products \u2014 Low temperature vaporized hydrogen peroxide<\/td>2022<\/td><\/tr>
37<\/td>ISO 11138-1<\/td>Sterilization of health care products \u2014 Biological indicators \u2014 Part 1: General requirements<\/td>2022<\/td><\/tr>
38<\/td>ISO 11140-1<\/td>Sterilization of health care products \u2014 Chemical indicators \u2014 Part 1: General requirements<\/td>2014<\/td><\/tr>
Cleanrooms & Controlled Environments<\/strong><\/td><\/tr>
39<\/td>ISO 14644-1<\/td>Cleanrooms and associated controlled environments \u2014 Part 1: Classification of air cleanliness<\/td>2021<\/td><\/tr>
40<\/td>ISO 14644-2<\/td>Cleanrooms and associated controlled environments \u2014 Part 2: Monitoring to provide evidence of cleanroom performance<\/td>2021<\/td><\/tr>
41<\/td>ISO 14644-3<\/td>Cleanrooms and associated controlled environments \u2014 Part 3: Test methods<\/td>2019<\/td><\/tr>
42<\/td>ISO 14644-4<\/td>Cleanrooms and associated controlled environments \u2014 Part 4: Design, construction and start-up<\/td>2022<\/td><\/tr>
43<\/td>ISO 14644-5<\/td>Cleanrooms and associated controlled environments \u2014 Part 5: Operations<\/td>2025<\/td><\/tr>
44<\/td>ISO 14644-7<\/td>Cleanrooms and associated controlled environments \u2014 Part 7: Separative devices<\/td>2004<\/td><\/tr>
45<\/td>ISO 14644-8<\/td>Cleanrooms and associated controlled environments \u2014 Part 8: Assessment of air cleanliness by chemical concentration<\/td>2022<\/td><\/tr>
46<\/td>ISO 14644-9<\/td>Cleanrooms and associated controlled environments \u2014 Part 9: Assessment of surface cleanliness for particle concentration<\/td>2022<\/td><\/tr>
47<\/td>ISO 14644-10<\/td>Cleanrooms and associated controlled environments \u2014 Part 10: Assessment of surface cleanliness for chemical contamination<\/td>2022<\/td><\/tr>
48<\/td>ISO 14644-12<\/td>Cleanrooms and associated controlled environments \u2014 Part 12: Specifications for monitoring air cleanliness<\/td>2018<\/td><\/tr>
49<\/td>ISO 14644-13<\/td>Cleanrooms and associated controlled environments \u2014 Part 13: Cleaning of surfaces to achieve defined levels of cleanliness<\/td>2026<\/td><\/tr>
50<\/td>ISO 14644-14<\/td>Cleanrooms and associated controlled environments \u2014 Part 14: Assessment of suitability for use of equipment<\/td>2026<\/td><\/tr>
51<\/td>ISO 14644-15<\/td>Cleanrooms and associated controlled environments \u2014 Part 15: Assessment of suitability for use of equipment<\/td>2017<\/td><\/tr>
52<\/td>ISO 14644-16<\/td>Cleanrooms and associated controlled environments \u2014 Part 16: Energy efficiency in cleanrooms<\/td>2019<\/td><\/tr>
53<\/td>ISO 14644-17<\/td>Cleanrooms and associated controlled environments \u2014 Part 17: Particle deposition rate applications<\/td>2021<\/td><\/tr>
54<\/td>ISO 14644-18<\/td>Cleanrooms and associated controlled environments \u2014 Part 18: Assessment of suitability of consumables<\/td>2023<\/td><\/tr>
Software & Digital Health Standards<\/strong><\/td><\/tr>
55<\/td>IEC 62304<\/td>Medical device software \u2014 Software life cycle processes<\/td>2021<\/td><\/tr>
56<\/td>IEC 62366-1<\/td>Medical devices \u2014 Part 1: Application of usability engineering<\/td>2021<\/td><\/tr>
57<\/td>IEC\/TR 62366-2<\/td>Medical devices \u2014 Part 2: Guidance on the application of usability engineering<\/td>2016<\/td><\/tr>
58<\/td>IEC 81001-5-1<\/td>Health software and health IT systems safety, effectiveness and security \u2014 Part 5-1: Security \u2014 Activities in the product life cycle<\/td>2021<\/td><\/tr>
59<\/td>IEC 82304-1<\/td>Health software \u2014 Part 1: General requirements for product safety<\/td>2021<\/td><\/tr>
60<\/td>ISO\/IEC 29138-1<\/td>Information technology \u2014 User interface accessibility \u2014 Part 1: User accessibility needs<\/td>2024<\/td><\/tr>
61<\/td>ISO 27799<\/td>Health informatics \u2014 Information security management in health using ISO\/IEC 27002<\/td>2025<\/td><\/tr>
62<\/td>ISO 81001-1<\/td>Health software and health IT systems safety, effectiveness and security \u2014 Part 1: Principles and concepts<\/td>2021<\/td><\/tr>
63<\/td>IEC 80001-1<\/td>Application of risk management for IT-networks incorporating medical devices \u2014 Part 1: Safety, effectiveness and security<\/td>2021<\/td><\/tr>
In Vitro Diagnostic (IVD) Standards<\/strong><\/td><\/tr>
64<\/td>ISO 15189<\/td>Medical laboratories \u2014 Requirements for quality and competence<\/td>2022<\/td><\/tr>
65<\/td>ISO 22367<\/td>Medical laboratories \u2014 Application of risk management to medical laboratories<\/td>2026<\/td><\/tr>
66<\/td>ISO 23640<\/td>In vitro diagnostic medical devices \u2014 Evaluation of stability of in vitro diagnostic reagents<\/td>2011<\/td><\/tr>
67<\/td>ISO 17511<\/td>In vitro diagnostic medical devices \u2014 Requirements for establishing metrological traceability<\/td>2026<\/td><\/tr>
68<\/td>ISO 20916<\/td>In vitro diagnostic medical devices \u2014 Clinical performance studies using specimens from human subjects \u2014 Good study practice<\/td>2025<\/td><\/tr>
69<\/td>ISO 5649<\/td>Medical laboratories \u2014 Concepts and specifications for the design, development, implementation and use of laboratory-developed tests<\/td>2024<\/td><\/tr>
70<\/td>ISO 20387<\/td>Biotechnology \u2014 Biobanking \u2014 General requirements for biobanking<\/td>2018<\/td><\/tr>
71<\/td>ISO 20395<\/td>Biotechnology \u2014 Requirements for evaluating the performance of quantification methods for nucleic acid target sequences \u2014 qPCR and dPCR<\/td>2019<\/td><\/tr>
72<\/td>CLSI EP Series<\/td>IVD performance evaluation standards<\/td>Various dates<\/td><\/tr>
Medical Electrical Equipment (IEC 60601 Series)<\/strong><\/td><\/tr>
73<\/td>IEC 60601-1-8<\/td>Medical electrical equipment \u2014 Part 1-8: General requirements for basic safety and essential performance \u2014 Collateral standard: Alarm systems<\/td>2006<\/td><\/tr>
74<\/td>IEC 60601-1-11<\/td>Medical electrical equipment \u2014 Part 1-11: General requirements for basic safety and essential performance \u2014 Collateral standard: Home healthcare environment<\/td>2025<\/td><\/tr>
75<\/td>IEC 60601-1-12<\/td>Medical electrical equipment \u2014 Part 1-12: General requirements for basic safety and essential performance \u2014 Collateral standard: Emergency medical services environment<\/td>2014<\/td><\/tr>
76<\/td>IEC 80601-2-61<\/td>Medical electrical equipment \u2014 Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment<\/td>2026<\/td><\/tr>
77<\/td>IEC 80601-2-69<\/td>Medical electrical equipment \u2014 Part 2-69: Particular requirements for the basic safety and essential performance of oxygen concentrator equipment<\/td>2026<\/td><\/tr>
78<\/td>IEC 80601-2-74<\/td>Medical electrical equipment \u2014 Part 2-74: Particular requirements for basic safety and essential performance of respiratory humidifying equipment<\/td>2026<\/td><\/tr>
79<\/td>IEC 80601-2-49<\/td>Medical electrical equipment \u2014 Part 2-49: Particular requirements for the basic safety and essential performance of multifunction patient monitoring equipment<\/td>2018<\/td><\/tr>
80<\/td>IEC 80601-2-77<\/td>Medical electrical equipment \u2014 Part 2-77: Particular requirements for the basic safety and essential performance of robotically assisted surgical equipment<\/td>2019<\/td><\/tr>
81<\/td>IEC 80601-2-78<\/td>Medical electrical equipment \u2014 Part 2-78: Particular requirements for basic safety and essential performance of medical robots for rehabilitation<\/td>2019<\/td><\/tr>
82<\/td>IEC 80601-2-89<\/td>Medical electrical equipment \u2014 Part 2-89: Particular requirements for the basic safety and essential performance of medical beds for children<\/td>2025<\/td><\/tr>
Labelling & Symbols Standards<\/strong><\/td><\/tr>
83<\/td>ISO 20417<\/td>Medical devices \u2014 Information to be supplied by the manufacturer<\/td>2026<\/td><\/tr>
84<\/td>ISO 15223-1<\/td>Medical devices \u2014 Symbols to be used with information to be supplied by the manufacturer \u2014 Part 1: General requirements<\/td>2021<\/td><\/tr>
85<\/td>ISO 15223-2<\/td>Medical devices \u2014 Symbols to be used with medical device labels, labelling, and information to be supplied \u2014 Part 2: Symbol development, selection and validation<\/td>2010<\/td><\/tr>
86<\/td>ISO 18113-1<\/td>In vitro diagnostic medical devices \u2014 Information supplied by the manufacturer (labelling) \u2014 Part 1: Terms, definitions, and general requirements<\/td>2022<\/td><\/tr>
87<\/td>ISO 18113-2<\/td>In vitro diagnostic medical devices \u2014 Information supplied by the manufacturer (labelling) \u2014 Part 2: In vitro diagnostic reagents for professional use<\/td>2022<\/td><\/tr>
88<\/td>ISO 18113-3<\/td>In vitro diagnostic medical devices \u2014 Information supplied by the manufacturer (labelling) \u2014 Part 3: In vitro diagnostic instruments for professional use<\/td>2022<\/td><\/tr>
89<\/td>ISO 18113-4<\/td>In vitro diagnostic medical devices \u2014 Information supplied by the manufacturer (labelling) \u2014 Part 4: In vitro diagnostic reagents for self-testing<\/td>2022<\/td><\/tr>
90<\/td>ISO 18113-5<\/td>In vitro diagnostic medical devices \u2014 Information supplied by the manufacturer (labelling) \u2014 Part 5: In vitro diagnostic instruments for self-testing<\/td>2022<\/td><\/tr>
Quality Management & Risk Management Standards<\/strong><\/td><\/tr>
91<\/td>ISO 13485<\/td>Medical devices \u2014 Quality management systems \u2014 Requirements for regulatory purposes<\/td>2025<\/td><\/tr>
92<\/td>ISO 14971<\/td>Medical devices \u2014 Application of risk management to medical devices<\/td>2025<\/td><\/tr>
93<\/td>ISO\/TR 24971<\/td>Medical devices \u2014 Guidance on the application of ISO 14971<\/td>2020<\/td><\/tr>
94<\/td>ISO 15378<\/td>Primary packaging materials for medicinal products \u2014 Particular requirements for the application of ISO 9001:2015, with reference to good manufacturing practice (GMP)<\/td>2023<\/td><\/tr>
95<\/td>ISO 7101<\/td>Healthcare organization management \u2014 Management systems for quality in healthcare organizations \u2014 Requirements<\/td>2023<\/td><\/tr>
96<\/td>ISO 35001<\/td>Biorisk management for laboratories and other related organisations<\/td>2019<\/td><\/tr>
Implants & Surgical Devices Standards<\/strong><\/td><\/tr>
97<\/td>ISO 14630<\/td>Non-active surgical implants \u2014 General requirements<\/td>2024<\/td><\/tr>
98<\/td>ISO 5832-1<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 1: Wrought stainless steel<\/td>2024<\/td><\/tr>
99<\/td>ISO 5832-2<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 2: Unalloyed titanium<\/td>2025<\/td><\/tr>
100<\/td>ISO 5832-3<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 3: Wrought titanium 6-aluminium 4-vanadium alloy<\/td>2021<\/td><\/tr>
101<\/td>ISO 5832-4<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 4: Cobalt-chromium-molybdenum casting alloy<\/td>2024<\/td><\/tr>
102<\/td>ISO 5832-5<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 5: Wrought cobalt-chromium-tungsten-nickel<\/td>2022<\/td><\/tr>
103<\/td>ISO 5832-6<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 6: Wrought cobalt-nickel-chromium-molybdenum alloy<\/td>2022<\/td><\/tr>
104<\/td>ISO 5832-11<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 11: Wrought titanium 6-aluminium 7-niobium alloy<\/td>2024<\/td><\/tr>
105<\/td>ISO 5832-12<\/td>Implants for surgery \u2014 Metallic materials \u2014 Part 12: Wrought cobalt-chromium-molybdenum alloy<\/td>2019<\/td><\/tr>
106<\/td>ISO 5834-1<\/td>Implants for surgery \u2014 Ultra-high-molecular-weight polyethylene \u2014 Part 1: Powder form<\/td>2025<\/td><\/tr>
107<\/td>ISO 5834-2<\/td>Implants for surgery \u2014 Ultra-high-molecular-weight polyethylene \u2014 Part 2: Moulded forms<\/td>2025<\/td><\/tr>
108<\/td>ISO 5834-3<\/td>Implants for surgery \u2014 Ultra-high-molecular-weight polyethylene \u2014 Part 3: Accelerated ageing methods<\/td>2025<\/td><\/tr>
109<\/td>ISO 5834-4<\/td>Implants for surgery \u2014 Ultra-high-molecular-weight polyethylene \u2014 Part 4: Oxidation index measurement method<\/td>2025<\/td><\/tr>
110<\/td>ISO 5834-5<\/td>Implants for surgery \u2014 Ultra-high-molecular-weight polyethylene \u2014 Part 5: Morphology assessment method<\/td>2025<\/td><\/tr>
111<\/td>ISO 5840-1<\/td>Cardiovascular implants \u2014 Cardiac valve prostheses \u2014 Part 1: General requirements<\/td>2021<\/td><\/tr>
112<\/td>ISO 5840-2<\/td>Cardiovascular implants \u2014 Cardiac valve prostheses \u2014 Part 2: Surgically implanted heart valve substitutes<\/td>2021<\/td><\/tr>
113<\/td>ISO 5840-3<\/td>Cardiovascular implants \u2014 Cardiac valve prostheses \u2014 Part 3: Heart valve substitutes implanted by transcatheter techniques<\/td>2021<\/td><\/tr>
114<\/td>ISO 14607<\/td>Non-active surgical implants \u2014 Mammary implants \u2014 Specific requirements<\/td>2024<\/td><\/tr>
115<\/td>ISO 21534<\/td>Non-active surgical implants \u2014 Joint replacement implants \u2014 Particular requirements<\/td>2021<\/td><\/tr>
116<\/td>ISO 21535<\/td>Non-active surgical implants \u2014 Joint replacement implants \u2014 Specific requirements for hip-joint replacement implants<\/td>2023<\/td><\/tr>
117<\/td>ISO 21536<\/td>Non-active surgical implants \u2014 Joint replacement implants \u2014 Specific requirements for knee-joint replacement implants<\/td>2023<\/td><\/tr>
118<\/td>ISO 25539-1<\/td>Cardiovascular implants \u2014 Endovascular devices \u2014 Part 1: Endovascular prostheses<\/td>2022<\/td><\/tr>
119<\/td>ISO 25539-2<\/td>Cardiovascular implants \u2014 Endovascular devices \u2014 Part 2: Vascular stents<\/td>2020<\/td><\/tr>
120<\/td>ISO 25539-3<\/td>Cardiovascular implants \u2014 Endovascular devices \u2014 Part 3: Vena cava filters<\/td>2024<\/td><\/tr>
121<\/td>ISO 7198<\/td>Cardiovascular implants and extracorporeal systems \u2014 Vascular prostheses \u2014 Tubular vascular grafts and vascular patches<\/td>2016<\/td><\/tr>
122<\/td>ISO 14708-1<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 1: General requirements for safety, marking and for information to be provided by the manufacturer<\/td>2014<\/td><\/tr>
123<\/td>ISO 14708-2<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 2: Cardiac pacemakers<\/td>2025<\/td><\/tr>
124<\/td>ISO 14708-3<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 3: Implantable neurostimulators<\/td>2017<\/td><\/tr>
125<\/td>ISO 14708-4<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 4: Implantable infusion pump systems<\/td>2022<\/td><\/tr>
126<\/td>ISO 14708-5<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 5: Circulatory support devices<\/td>2020<\/td><\/tr>
127<\/td>ISO 14708-6<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 6: Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (including implantable defibrillators)<\/td>2025<\/td><\/tr>
128<\/td>ISO 14708-7<\/td>Implants for surgery \u2014 Active implantable medical devices \u2014 Part 7: Particular requirements for cochlear and auditory brainstem implant systems<\/td>2026<\/td><\/tr>
Post-Market Surveillance & Vigilance Standards<\/strong><\/td><\/tr>
129<\/td>ISO\/TR 20416<\/td>Medical devices \u2014 Post-market surveillance for manufacturers<\/td>2020<\/td><\/tr>
130<\/td>ISO\/TS 5137<\/td>Medical device maintenance management programme for healthcare delivery organizations (HDO)<\/td>2026<\/td><\/tr>
131<\/td>ISO\/TR 18965<\/td>Medical devices \u2014 Examples of the application of the risk management process to cardiac valve replacement and repair systems<\/td>2025<\/td><\/tr>
Cosmetic & Personal Care Product Standards<\/strong><\/td><\/tr>
132<\/td>ISO 22716<\/td>Cosmetics \u2014 Good Manufacturing Practices (GMP) \u2014 Guidelines on Good Manufacturing Practices<\/td>2022<\/td><\/tr>
133<\/td>ISO 24444<\/td>Cosmetics \u2014 Sun protection test methods \u2014 In vivo determination of the sun protection factor (SPF)<\/td>2019<\/td><\/tr>
134<\/td>ISO 24442<\/td>Cosmetics \u2014 Sun protection test methods \u2014 In vivo determination of sunscreen UVA protection<\/td>2022<\/td><\/tr>
135<\/td>ISO 23675<\/td>Cosmetics \u2014 Sun protection test methods \u2014 In vitro determination of sun protection factor (SPF)<\/td>2024<\/td><\/tr>
136<\/td>ISO 23698<\/td>Cosmetics \u2014 Measurement of the sunscreen efficacy by diffuse reflectance spectroscopy<\/td>2024<\/td><\/tr>
137<\/td>ISO 16128-1<\/td>Cosmetics \u2014 Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients \u2014 Part 1: Definitions for ingredients<\/td>2016<\/td><\/tr>
138<\/td>ISO 16128-2<\/td>Cosmetics \u2014 Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients \u2014 Part 2: Criteria for ingredients and products<\/td>2017<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

How Satori One Click Solutions LLP Can Help<\/strong><\/h2>\n\n\n\n

We support medical device manufacturers with:<\/p>\n\n\n\n